Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway
Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S
Cancer research · 130 citas
Cómo se estudió
- Diseño
- Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas, más trabajo en animales o laboratorio
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Institute of Environmental Health Sciences
- Gobierno
- NIEHS NIH HHS
- Subvenciones
- National Institute of Environmental Health Sciences (ES-08258); National Institute of Environmental Health Sciences (R01 ES008258)
Según 2 financiadores declarados.
Publicación
- Publicado
- 2010-04-13 · Cancer Res · vol. 70 · número 9 · págs. 3594–3605
- Editorial
- American Association for Cancer Research
- Citado
- 221 citas · más que el 100% de estudios similares · 14.6× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 53 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Microbial Metabolism and Applications · Bioactive Compounds in Plants · Phytochemicals and Antioxidant Activities
- Palabras clave
- Protein kinase B, MAPK/ERK pathway, Cell growth, PI3K/AKT/mTOR pathway, Cancer research, Kinase, Chemistry, Biology, Signal transduction, Biochemistry
- MeSH
- cell line, tumor, animals, mice, inbred balb c, humans, mice, mice, nude, fruit, breast neoplasms, phenols, flavonoids, plasminogen activator inhibitor 1, tissue inhibitor of metalloproteinase-1, plant extracts, xenograft model antitumor assays, signal transduction, apoptosis, cell growth processes, cell movement, beverages, female, proto-oncogene proteins c-akt, matrix metalloproteinase 2, matrix metalloproteinase 9, urokinase-type plasminogen activator, phosphatidylinositol 3-kinases, polyphenols, matrix metalloproteinase inhibitors, blueberry plants
6 autores
- Lynn S. Adams🇺🇸University of Rhode Island; City of Hope
- Sheryl Phung🇺🇸University of Rhode Island; City of Hope
- Natalie Yee🇺🇸University of Rhode Island; City of Hope
- Navindra Persaud Seeram🇺🇸University of Rhode Island; City of Hope
- Liya Li🇺🇸University of Rhode Island; City of Hope
- Shiuan Chen🇺🇸 · autor de correspondenciaUniversity of Rhode Island; City of Hope
Resumen
El texto original del estudio, en el idioma en que se publicó.
Dietary phytochemicals are known to exhibit a variety of anticarcinogenic properties. This study investigated the chemopreventive activity of blueberry extract in triple-negative breast cancer cell lines in vitro and in vivo. Blueberry decreased cell proliferation in HCC38, HCC1937, and MDA-MB-231 cells with no effect on the nontumorigenic MCF-10A cell line. Decreased metastatic potential of MDA-MB-231 cells by blueberry was shown through inhibition of cell motility using wound-healing assays and migration through a polyethylene terephthalate membrane. Blueberry treatment decreased the activity of matrix metalloproteinase-9 and the secretion of urokinase-type plasminogen activator while increasing tissue inhibitor of metalloproteinase-1 and plasminogen activator inhibitor-1 secretion in MDA-MB-231 conditioned medium as shown by Western blotting. Cell signaling pathways that control the expression/activation of these processes were investigated via Western blotting and reporter gene assay. Treatment with blueberry decreased phosphatidylinositol 3-kinase (PI3K)/AKT and NFkappaB activation in MDA-MB-231 cells, where protein kinase C and extracellular signal-regulated kinase (ERK) were not affected. In vivo, the efficacy of blueberry to inhibit triple-negative breast tumor growth was evaluated using the MDA-MB-231 xenograft model. Tumor weight and proliferation (Ki-67 expression) were decreased in blueberry-treated mice, where apoptosis (caspase-3 expression) was increased compared with controls. Immunohistochemical analysis of tumors from blueberry-fed mice showed decreased activation of AKT and p65 NFkappaB signaling proteins with no effect on the phosphorylation of ERK. These data illustrate the inhibitory effect of blueberry phytochemicals on the growth and metastatic potential of MDA-MB-231 cells through modulation of the PI3K/AKT/NFkappaB pathway.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.